Surgical & Medical Instruments & Apparatus Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Surgical & Medical Instruments & Apparatus
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-06-14 | DXCM | Dexcom Inc | Augustinos Nicholas | Dir | S - Sale | $146.32 | -1,208 | 23,632 | -5% | -$176,755 | ||||||
2019-06-13 | RMED | Ra Medical Systems, Inc. | Kraws Jeffrey J | Co-Pres | S - Sale | $3.08 | -18,021 | 164,433 | -10% | -$55,438 | ||||||
2019-06-13 | RMED | Ra Medical Systems, Inc. | Jackson Andrew C. | CFO | S - Sale | $3.08 | -5,134 | 34,348 | -13% | -$15,794 | ||||||
2019-06-13 | TNDM | Tandem Diabetes Care Inc | Roeder Douglas A | Dir | S - Sale | $70.07 | -35,688 | 12,872 | -73% | -$2,500,647 | ||||||
| D | 2019-06-13 | XENT | Intersect Ent, Inc. | Stimson Susan P | Chief Strategy Officer | S - Sale+OE | $25.00 | -350 | 35,982 | -1% | -$8,750 | |||||
2019-06-13 | OFIX | Orthofix Medical Inc. | Mason Brad | CEO | S - Sale | $51.11 | -8,890 | 155,930 | -5% | -$454,327 | ||||||
2019-06-14 | INFU | Infusystem Holdings, Inc | Shuda Scott | Dir, 10% | P - Purchase | $4.51 | +4,723 | 3,521,517 | 0% | +$21,321 | ||||||
2019-06-13 | HAE | Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | S - Sale | $110.58 | -94 | 2,789 | -3% | -$10,395 | ||||||
| M | 2019-06-13 | REPR | Repro Med Systems Inc | Manko Joseph M. Jr. | Dir, 10% | P - Purchase | $2.18 | +7,847 | 11,296,726 | 0% | +$17,083 | |||||
2019-06-13 | IRTC | Irhythm Technologies, Inc. | Bairey Merz Cathleen Noel | Dir | S - Sale | $76.40 | -1,209 | 3,844 | -24% | -$92,368 | ||||||
| D | 2019-06-12 | GKOS | Glaukos Corp | Gilliam Joseph E | CFO, SVP Corporate Development | S - Sale+OE | $73.25 | -2,500 | 47,063 | -5% | -$183,125 | |||||
2019-06-13 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP CTO | S - Sale | $145.32 | -5,099 | 127,605 | -4% | -$741,008 | ||||||
| D | 2019-06-13 | BAX | Baxter International Inc | Forsyth John D | Dir | S - Sale+OE | $78.21 | -1,320 | 31,459 | -4% | -$103,237 | |||||
| D | 2019-06-14 | NEPH | Nephros Inc | Astor Andrew | CFO, COO | P - Purchase | $0.64 | +35,000 | 532,903 | +7% | +$22,400 | |||||
| D | 2019-06-14 | NEPH | Nephros Inc | Evans Daron | Pres, CEO | P - Purchase | $0.60 | +43,172 | 1,268,258 | +4% | +$25,761 | |||||
2019-06-12 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.67 | +1,500 | 18,481,795 | 0% | +$1,007 | ||||||
2019-06-11 | PEN | Penumbra Inc | Elsesser Adam | COB, CEO, Pres | S - Sale | $165.08 | -8,000 | 1,097,982 | -1% | -$1,320,650 | ||||||
2019-06-12 | HAE | Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | S - Sale | $109.37 | -39 | 2,883 | -1% | -$4,265 | ||||||
2019-06-12 | HAE | Haemonetics Corp | Bolorforosh Said | EVP, CTO | S - Sale | $109.37 | -69 | 2,141 | -3% | -$7,547 | ||||||
| DM | 2019-06-11 | TCMD | Tactile Systems Technology Inc | Folkes Robert J. | COO | S - Sale+OE | $53.27 | -5,000 | 96,808 | -5% | -$266,375 | |||||
2019-06-11 | TTOO | T2 Biosystems, Inc. | Cima Michael J. | Dir | S - Sale | $1.43 | -3,240 | 213,178 | -1% | -$4,633 | ||||||
2019-06-12 | HAE | Haemonetics Corp | Scanlan Jacqueline | SVP, Global HR | S - Sale | $109.37 | -108 | 5,674 | -2% | -$11,812 | ||||||
2019-06-11 | TTOO | T2 Biosystems, Inc. | Lapidus Stanley | Dir | S - Sale | $1.44 | -9,000 | 53,010 | -15% | -$12,960 | ||||||
2019-06-11 | TTOO | T2 Biosystems, Inc. | Cumming John W | Dir | S - Sale | $1.43 | -3,420 | 23,580 | -13% | -$4,891 | ||||||
2019-06-11 | TTOO | T2 Biosystems, Inc. | Elsbree David B | Dir | S - Sale | $1.44 | -3,600 | 93,108 | -4% | -$5,184 | ||||||
2019-06-12 | HAE | Haemonetics Corp | Basil Michelle L | EVP, GC | S - Sale | $109.37 | -231 | 13,138 | -2% | -$25,264 | ||||||
2019-06-12 | HAE | Haemonetics Corp | Burke William P. Mr. | EVP, CFO | S - Sale | $109.37 | -190 | 14,460 | -1% | -$20,780 | ||||||
2019-06-12 | HAE | Haemonetics Corp | Simon, Christopher | Pres, CEO | S - Sale | $109.37 | -1,248 | 246,151 | -1% | -$136,494 | ||||||
| DM | 2019-06-11 | NVCR | Novocure Ltd | Danziger Asaf | CEO | S - Sale+OE | $55.16 | -47,271 | 258,311 | -15% | -$2,607,615 | |||||
2019-06-12 | BDX | Becton Dickinson & Co | Campion Simon D | EVP, Segment Pres | S - Sale | $236.94 | -2,903 | 9,408 | -24% | -$687,837 | ||||||
| DM | 2019-06-10 | IRMD | Iradimed Corp | Johnson Brent | EVP of WW Sales, Mktg | S - Sale+OE | $20.57 | -3,000 | 1,368 | -69% | -$61,720 | |||||
| D | 2019-06-10 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Chief Commercial Officer | S - Sale+OE | $18.00 | -200 | 19,273 | -1% | -$3,600 | |||||
| D | 2019-06-10 | TCMD | Tactile Systems Technology Inc | Rishe Bryan | SVP, Sales | S - Sale+OE | $53.27 | -4,812 | 45,862 | -9% | -$256,355 | |||||
2019-06-10 | HAE | Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | S - Sale | $104.38 | -192 | 2,922 | -6% | -$20,041 | ||||||
2019-06-10 | NVCR | Novocure Ltd | Shah Pritesh | Chief Commercial Officer | S - Sale | $55.05 | -1,130 | 76,212 | -1% | -$62,212 | ||||||
| D | 2019-06-10 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale+OE | $55.05 | -5,000 | 69,504 | -7% | -$275,266 | |||||
| D | 2019-06-10 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $118.16 | -6,651 | 296,677 | -2% | -$785,862 | |||||
2019-06-10 | DXCM | Dexcom Inc | Sayer Kevin R | Pres, CEO, COB | S - Sale | $132.74 | -6,000 | 294,100 | -2% | -$796,444 | ||||||
2019-06-10 | DXCM | Dexcom Inc | Murphy Patrick Michael | SVP Legal Affairs | S - Sale | $127.03 | -400 | 35,460 | -1% | -$50,812 | ||||||
| D | 2019-06-10 | ICUI | Icu Medical Inc/de | McGrody Kevin J | Controller | S - Sale+OE | $231.68 | -7,344 | 668 | -92% | -$1,701,435 | |||||
| D | 2019-06-10 | BDX | Becton Dickinson & Co | Kaltenbach Patrick | EVP, Pres Life Sciences | S - Sale+OE | $241.03 | -191 | 16,207 | -1% | -$46,037 | |||||
2019-06-06 | SIBN | Si-Bone, Inc. | Yerby Scott A | CTO | S - Sale | $17.19 | -648 | 194,147 | 0% | -$11,139 | ||||||
| M | 2019-06-06 | NVRO | Nevro Corp | Weatherman Elizabeth H | Dir | P - Purchase | $61.22 | +8,183 | 14,883 | +122% | +$500,981 | |||||
| DM | 2019-06-06 | HAE | Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | S - Sale+OE | $103.26 | -1,185 | 3,114 | -28% | -$122,361 | |||||
2019-06-07 | HAE | Haemonetics Corp | Scanlan Jacqueline | SVP, Global HR | S - Sale | $103.38 | -208 | 5,782 | -3% | -$21,503 | ||||||
| DM | 2019-06-06 | HAE | Haemonetics Corp | Basil Michelle L | EVP, GC | S - Sale+OE | $103.38 | -13,335 | 13,369 | -50% | -$1,378,582 | |||||
2019-06-07 | HAE | Haemonetics Corp | Burke William P. Mr. | EVP, CFO | S - Sale | $103.38 | -411 | 14,650 | -3% | -$42,489 | ||||||
| D | 2019-06-06 | NVCR | Novocure Ltd | Ambrogi Michael J. | COO | S - Sale+OE | $54.79 | -5,999 | 185,674 | -3% | -$328,661 | |||||
2019-06-07 | HAE | Haemonetics Corp | Simon, Christopher | Pres, CEO | S - Sale | $103.38 | -2,834 | 247,399 | -1% | -$292,979 | ||||||
| D | 2019-06-07 | IRMD | Iradimed Corp | Johnson Brent | EVP of WW Sales, Mktg | S - Sale+OE | $20.00 | -1,000 | 1,368 | -42% | -$20,000 | |||||
2019-06-05 | NVTR | Nuvectra Corp | Hanchin Joseph Paul | Pres | S - Sale | $3.98 | -7,900 | 45,377 | -15% | -$31,442 | ||||||
2019-06-05 | NVRO | Nevro Corp | Oboyle Kevin C | Dir | P - Purchase | $60.00 | +1,675 | 8,375 | +25% | +$100,500 | ||||||
| D | 2019-06-05 | TFX | Teleflex Inc | Smith Benson | Dir | S - Sale+OE | $296.00 | -8,500 | 76,800 | -10% | -$2,516,004 | |||||
2019-06-05 | DXCM | Dexcom Inc | Balo Andrew K | * | S - Sale | $125.00 | -7,825 | 69,392 | -10% | -$978,125 | ||||||
| D | 2019-06-05 | NVCR | Novocure Ltd | Ambrogi Michael J. | COO | S - Sale+OE | $54.14 | -17,500 | 185,674 | -9% | -$947,485 | |||||
| M | 2019-06-04 | ATRC | Atricure, Inc. | Wade M. Andrew | SVP, CFO | S - Sale | $30.00 | -10,811 | 156,013 | -6% | -$324,330 | |||||
2019-06-03 | PEN | Penumbra Inc | Kosaraju Sridhar | CFO, Head of Strategy | S - Sale | $142.89 | -5,000 | 176,351 | -3% | -$714,461 | ||||||
2019-06-05 | PODD | Insulet Corp | Petrovic Shacey | Pres, CEO | S - Sale | $113.00 | -895 | 95,559 | -1% | -$101,135 | ||||||
2019-06-05 | INO | Inovio Pharmaceuticals, Inc. | Humeau Laurent | Chief Scientific Officer | P - Purchase | $2.50 | +20,000 | 45,833 | +77% | +$50,000 | ||||||
2019-06-04 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.63 | +202 | 18,480,295 | 0% | +$127 | ||||||
2019-06-03 | SRDX | Surmodics Inc | Maharaj Gary R | Pres, CEO | S - Sale | $40.95 | -5,000 | 152,205 | -3% | -$204,740 | ||||||
| DM | 2019-06-03 | NVCR | Novocure Ltd | Ambrogi Michael J. | COO | S - Sale+OE | $52.62 | -35,000 | 185,674 | -16% | -$1,841,741 | |||||
| M | 2019-06-03 | INSP | Inspire Medical Systems, Inc. | Ban Randy | SVP, Sales, Marketing | S - Sale | $55.39 | -10,000 | 900 | -92% | -$553,864 | |||||
2019-06-03 | SIBN | Si-Bone, Inc. | Yerby Scott A | CTO | S - Sale | $16.62 | -376 | 194,795 | 0% | -$6,249 | ||||||
| D | 2019-06-03 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Chief Commercial Officer | S - Sale+OE | $16.62 | -1,000 | 19,273 | -5% | -$16,620 | |||||
2019-06-04 | BSX | Boston Scientific Corp | Pierce David A | EVP,Pres MedSurg | S - Sale | $38.60 | -1,650 | 24,201 | -6% | -$63,684 | ||||||
2019-06-04 | BDX | Becton Dickinson & Co | Kaltenbach Patrick | EVP, Pres Life Sciences | S - Sale | $235.00 | -275 | 16,207 | -2% | -$64,625 | ||||||
2019-06-03 | DXCM | Dexcom Inc | Abbey Donald | EVP Quality, Regulatory Aff | S - Sale | $121.08 | -9,030 | 86,393 | -9% | -$1,093,352 | ||||||
2019-06-04 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | P - Purchase | $4.60 | +10,000 | 638,485 | +2% | +$46,000 | ||||||
| D | 2019-06-03 | TNDM | Tandem Diabetes Care Inc | Berger David B | EVP, Chief Legal, Compliance | S - Sale+OE | $67.76 | -2,000 | 3,511 | -36% | -$135,520 | |||||
| D | 2019-06-03 | RMD | Resmed Inc | Hollingshead James | Pres, Sleep Business | S - Sale+OE | $114.01 | -1,600 | 78,223 | -2% | -$182,416 | |||||
2019-06-03 | BSX | Boston Scientific Corp | Wang Xin Warren | SVP, Pres, Asia Pacific | S - Sale | $38.45 | -10,000 | 75,469 | -12% | -$384,534 | ||||||
| D | 2019-06-03 | BSX | Boston Scientific Corp | Pierce David A | EVP,Pres MedSurg | S - Sale+OE | $38.45 | -5,140 | 25,851 | -17% | -$197,650 | |||||
| D | 2019-06-03 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale+OE | $114.01 | -4,367 | 117,883 | -4% | -$497,882 | |||||
| M | 2019-05-31 | INO | Inovio Pharmaceuticals, Inc. | Kim Jong Joseph | CEO | S - Sale | $2.36 | -2,129,553 | 2,001,580 | -52% | -$5,017,653 | |||||
| M | 2019-05-30 | INSP | Inspire Medical Systems, Inc. | Erony Joyce | Dir | S - Sale | $55.75 | -66,568 | 537,043 | -11% | -$3,711,287 | |||||
2019-06-03 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.63 | +2,000 | 18,480,093 | 0% | +$1,262 | ||||||
| D | 2019-05-31 | PODD | Insulet Corp | Crawford Sally | Dir | S - Sale+OE | $108.60 | -28,347 | 28,469 | -50% | -$3,078,484 | |||||
2019-05-31 | CRY | Cryolife Inc | Capps Scott B | VP, Clinical Research | S - Sale | $28.55 | -2,000 | 141,079 | -1% | -$57,100 | ||||||
2019-05-30 | NVCR | Novocure Ltd | Doyle William F | Exec COB | S - Sale | $53.07 | -48,100 | 846,463 | -5% | -$2,552,523 | ||||||
2019-05-30 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $112.34 | -3,000 | 79,514 | -4% | -$337,020 | ||||||
2019-05-30 | GNMK | Genmark Diagnostics, Inc. | Ek John Frederick | CFO | S - Sale | $6.60 | -924 | 176,538 | -1% | -$6,098 | ||||||
2019-05-30 | GNMK | Genmark Diagnostics, Inc. | Stier Eric | SVP, GC | S - Sale | $6.60 | -1,564 | 237,552 | -1% | -$10,322 | ||||||
2019-05-30 | GNMK | Genmark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | S - Sale | $6.60 | -1,729 | 358,577 | 0% | -$11,411 | ||||||
2019-05-30 | GNMK | Genmark Diagnostics, Inc. | McNally James B. | SVP, Marketing, Bus. Dev. | S - Sale | $6.60 | -2,057 | 261,229 | -1% | -$13,576 | ||||||
2019-05-30 | GNMK | Genmark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | S - Sale | $6.60 | -1,729 | 206,918 | -1% | -$11,411 | ||||||
2019-05-30 | GNMK | Genmark Diagnostics, Inc. | Mendel Scott | COO | S - Sale | $6.60 | -2,304 | 432,680 | -1% | -$15,206 | ||||||
2019-05-30 | GNMK | Genmark Diagnostics, Inc. | Massarany Hany | Pres, CEO | S - Sale | $6.60 | -10,369 | 1,349,519 | -1% | -$68,435 | ||||||
2019-05-30 | GNMK | Genmark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering, Tech Dev | S - Sale | $6.60 | -825 | 134,211 | -1% | -$5,445 | ||||||
2019-05-29 | NVCR | Novocure Ltd | Doyle William F | Exec COB | S - Sale | $53.09 | -1,900 | 894,563 | 0% | -$100,881 | ||||||
| D | 2019-05-29 | NVCR | Novocure Ltd | Phillips Charles G III | Dir | S - Sale+OE | $52.17 | -95,100 | 9,504 | -91% | -$4,961,198 | |||||
2019-05-29 | DXCM | Dexcom Inc | Blackford Quentin S. | EVP CFO | S - Sale | $118.95 | -8,874 | 91,740 | -9% | -$1,055,527 | ||||||
2019-05-29 | BSX | Boston Scientific Corp | Thepaut Eric Francis Yves | SVP, Pres, Eur, Mid-East, Afr | S - Sale | $38.03 | -22,047 | 88,978 | -20% | -$838,432 | ||||||
| D | 2019-05-28 | SIBN | Si-Bone, Inc. | Francis Laura | CFO | S - Sale+OE | $15.97 | -6,486 | 70,524 | -8% | -$103,560 | |||||
| M | 2018-04-13 | BDX | Becton Dickinson & Co | Burzik Catherine M | Dir | P - Purchase | $229.37 | +360 | 10,007 | +4% | +$82,573 | |||||
2019-04-17 | BDX | Becton Dickinson & Co | Burzik Catherine M | Dir | S - Sale | $223.04 | -45 | 10,007 | 0% | -$10,037 | ||||||
| M | 2019-05-24 | INSP | Inspire Medical Systems, Inc. | Erony Joyce | Dir | S - Sale | $54.27 | -44,053 | 603,611 | -7% | -$2,390,825 | |||||
| D | 2019-05-28 | TFX | Teleflex Inc | Klasko Stephen K. M.D. | Dir | S - Sale+OE | $295.81 | -200 | 736 | -21% | -$59,162 | |||||
2019-05-28 | INSP | Inspire Medical Systems, Inc. | Herbert Timothy P. | CEO, Pres | S - Sale | $52.55 | -25,000 | 457,849 | -5% | -$1,313,812 | ||||||
2019-05-29 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.63 | +3,500 | 18,478,093 | 0% | +$2,216 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |